Analytical aspects of thyroid antibodies estimation

References

• Hashimoto H. Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir (Berl) 1912; 97: 219–248
   Google Scholar
• Weetman AP. New aspects of thyroid immunity. Horm Res 1997; 48(Suppl. IV)51
   PubMedGoogle Scholar
• Tamai H, Kasagi K, Takaichi Y, Takamatsu J, Komaki G, Matsubayashi S, et al. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: Clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 1989; 69: 49–53
   PubMed Web of Science ®Google Scholar
• Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, Nagasawa Y, et al. Graves' disease following hypothyroidism due to Hashimoto's disease: Studies of eight cases. Clin Endocrinol (Oxf) 1990; 33: 687–698
   PubMed Web of Science ®Google Scholar
• Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 1992; 36: 211–214
   PubMed Web of Science ®Google Scholar
• Dunn JT, Ray SC. Variations in the structure of thyroglobulins from normal and goitrous human thyroids. J Clin Endocrinol Metab 1978; 47: 861–869
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Parkes AB, Premawardhana LD, Evans C, Lazarus JH. Thyroglobulin: Current aspects of its role in autoimmune thyroid disease and thyroid cancer. Minerva Med 2003; 94: 319–330
   PubMedGoogle Scholar
• McLachlan SM, Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies?. Thyroid 2004; 14: 510–520
   PubMed Web of Science ®Google Scholar
• Lisi S, Marino M, Pinchera A, Mazzi B, Di Cosmo C, Sellari-Franceschini S, Chiovato L. Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: Predominant localization in fibroadipose tissue. Thyroid 2002; 12: 351–360
   PubMedGoogle Scholar
• Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev 1998; 19: 673–716
   PubMed Web of Science ®Google Scholar
• Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, et al. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid 1997; 7: 867–877
   PubMed Web of Science ®Google Scholar
• Chazenbalk GD, Latrofa F, McLachlan SM, Rapoport B. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N-terminus of the thyrotropin receptor A-subunit. J Clin Endocrinol Metab 2004; 89: 1788–1793
   PubMedGoogle Scholar
• Minich WB, Lenzner C, Morgenthaler NG. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol 2004; 136: 129–136
   PubMedGoogle Scholar
• McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: Cloning, expression, and role as autoantigen in autoimmune thyroid disease. Endocr Rev 1992; 13: 192–206
   PubMed Web of Science ®Google Scholar
• Portmann L, Hamada N, Heinrich G, DeGroot LJ. Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: Possible identity with antimicrosomal antibody. J Clin Endocrinol Metab 1985; 61: 10013
   Google Scholar
• Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190: 14752
   Google Scholar
• Rapoport B, McLachlan SM. Thyroid autoimmunity. J Clin Invest 2001; 108: 1253–1259
   PubMed Web of Science ®Google Scholar
• Khoury EL, Hammond L, Bottazzo GF, Doniach D. Presence of the organspecific “microsomal” autoantigen on the surface of human thyroid cells in culture: Its involvement in complementmediated cytotoxicity. Clin Exp Immunol 1981; 45: 316–328
   PubMed Web of Science ®Google Scholar
• Jaume JC, Guo J, Pauls DL, Zakarija M, McKenzie JM, Egeland JA, et al. Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic “fingerprints”. J Clin Endocrinol Metab. 1999; 84: 1424–1431
   PubMed Web of Science ®Google Scholar
• Endo T, Kogai T, Nakazato M, Saito T, Kaneshige M, Onaya T. Autoantibody against Na+/I− symporter in the sera of patients with autoimmune thyroid disease. Biochem Biophys Res Comm 1996; 224: 92–95
   PubMedGoogle Scholar
• Heufelder AE, Joba W, Morgenthaler NG. Autoimmunity involving the human sodium/iodide symporter: Fact or fiction?. Exp Clin Endocrinol Diab 2001; 109: 35–40
   PubMed Web of Science ®Google Scholar
• Seissler J, Wagner S, Schott M, Lettmann M, Feldkamp J, Scherbaum WA, et al. Low frequency of autoantibodies to the human Na(+)/I( − ) symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 4630–4634
   PubMed Web of Science ®Google Scholar
• Katakura M, Yamada T, Aizawa T, Hiramatsu K, Yukimura Y, Ishihara M, et al. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metab 1987; 64: 4058
   Google Scholar
• Marino M, Chiovato L, Friedlander JA, Latrofa F, Pinchera A, McCluskey RT. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. J Clin Endocrinol Metab 1999; 84: 2468–2474
   PubMedGoogle Scholar
• Weetman AP. Autoimmune thyroid disease: Propagation and progression. Eur J Endocrinol 2003; 148: 1–9
   PubMed Web of Science ®Google Scholar
• Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960–963
   PubMed Web of Science ®Google Scholar
• Arscott PL, Baker JR, Jr. Apoptosis and thyroiditis. Clin Immunol Immunopathol 1998; 87: 207–217
   PubMedGoogle Scholar
• Weetman AP, De Groot LJ. Autoimmunity to the thyroid, www.thyroidmanager.org/thyroidbook.htm
   Google Scholar
• Czarnocka B, Ruf J, Ferrand M, et al. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190: 147–152
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Hannon WH, Flanders WD, Gunter EW, Spencer CA, et al. Serum thyrotropin, thyroxine and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab 2002; 87: 489–499
   PubMed Web of Science ®Google Scholar
• Zophel K, Saller B, Wunderlich G, Gruning T, Koch R, Wilde J, et al. Autoantibodies to thyroperoxidase (TPO antibody) in a large population of euthyroid subjects: Implications for the definition of TPO antibody reference intervals. Clin Lab 2003; 49: 591–600
   PubMedGoogle Scholar
• Feldt-Rasmussen. Anti-thyroid peroxidase antibodies in thyroid disorders and non thyroid autoimmune diseases. Autoimmunity 1991; 9: 245–251
   PubMedGoogle Scholar
• Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Rodgers H, et al. The incidence of thyroid disorders in the community; a twenty year follow up of the Whickham survey. Clin Endocrinol 1995; 43: 55–68
   PubMed Web of Science ®Google Scholar
• Estienne V, Duthoit C, Costanzo VD, Lejeune PJ, Rotondi M, Kornfeld S, et al. Multicenter study on TGPO autoantibodies prevalence in various thyroid and non-thyroid diseases: Relationships with thyroglobulin and thyroperoxidase autoantibody parameters. Eur J Endocrinol 1999; 141: 563–569
   PubMedGoogle Scholar
• Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003; 139: 346–351
   PubMed Web of Science ®Google Scholar
• Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3–126, (Guidelines Committee, National Academy of Clinical Biochemistry)
   PubMed Web of Science ®Google Scholar
• Demers LM, Spencer CA. Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol 2003; 58: 138–140
   PubMed Web of Science ®Google Scholar
• Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, et al. Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121–1127
   PubMed Web of Science ®Google Scholar
• Ruf J, Carayon P, Lissitzky S. Various expression of a unique anti-human thyroglobulin antibody repertoire in normal state and autoimmune disease. Eur J Immunol 1985; 15: 268–272
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen U, Rasmussen AK. Serum thyroglobulin (TG) in the presence of thyroglobulin autoantibodies (TGAb). Clinical and methodological relevance of the interaction between TG and TGAb in vivo and in vitro. J Endocrinol Invest 1985; 8: 571–576
   PubMedGoogle Scholar
• Spencer CA, Wang C, Fatemi S, Guttler RB, Takeuchi M, Kazarosyan M. Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121–1127
   PubMed Web of Science ®Google Scholar
• Ericsson UB, Christensen SB, Thorell JI. A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol 1985; 37: 154–162
   PubMedGoogle Scholar
• Di Cerbo A, Di Paoloa R, Menzaghi C, De Filippis V, Tahara K, Corda D, et al. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on the thyrotropin receptor. J Clin Endocrinol Metab 1999; 84: 3283–3292
   PubMed Web of Science ®Google Scholar
• Kosugi S, Ban T, Akamizu T, Valente W, Kohn LD. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. J Clin Endocrinol Metab 1993; 77: 19–24
   PubMedGoogle Scholar
• Nagayama Y, Rapoport B. Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: Selective role of receptor amino acids Ser25-Glu30. J Clin Endocrinol Metab 1992; 75: 1425–1430
   PubMedGoogle Scholar
• Ando T, Latif R, Daniel S, Eguchi K, Davies TF. Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinol 2004; 145: 5185–5193
   PubMedGoogle Scholar
• Shimojo N, Kohno Y, Yamaguchi K, Kikuoka S, Hoshioka A, Niimi H, et al. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 1996; 93: 11074–11079
   PubMed Web of Science ®Google Scholar
• Costagliola S, Many MC, Denef JF, Pohlenz J, Refetoff S, Vassart G. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest 2000; 105: 803–811
   PubMed Web of Science ®Google Scholar
• Kita M, Ahmad L, Marians RC, Vlase H, Unger P, Graves PN, et al. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease. Endocrinology 1999; 140: 1392–1398
   PubMed Web of Science ®Google Scholar
• Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, et al. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 2002; 168: 2789–2794
   PubMed Web of Science ®Google Scholar
• Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams RC, Jr, et al. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 1990; 86: 723–727
   PubMed Web of Science ®Google Scholar
• Southgate K, Creagh FM, Teece M, Kingswood C, Rees Smith B. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 1984; 20: 539–543
   PubMed Web of Science ®Google Scholar
• Shewring G, Rees-Smith B. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol 1982; 17: 409–417
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen U. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor. Clin Chem 1996; 42: 160–163
   PubMed Web of Science ®Google Scholar
• Ueta Y, Fukui H, Murakami M, Yamanouchi Y, Yamamoto R, Murao A, et al. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy. Thyroid 1999; 9: 179–182
   PubMedGoogle Scholar
• Gupta MK. Thyrotropin-receptor antibodies in thyroid diseases: Advances in detection techniques and clinical application. Clin Chem Acta 2000; 293: 1–29
   PubMedGoogle Scholar
• Kung AWC, Lau KS, Kohn LD. Epitope mapping of TSH receptor-blocking antibodies in Graves' disease that appear during pregnancy. J Clin Endocrinol Metab 2001; 86: 3647–3653
   PubMed Web of Science ®Google Scholar
• Kung AW, Lau KS, Kohn LD. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy. Thyroid 2000; 10: 909–917
   PubMed Web of Science ®Google Scholar
• Filetti S, Foti D, Costante G, Rapoport B. Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor antibodies. J Clin Endocrinol Metab 1991; 72: 1096–1101
   PubMedGoogle Scholar
• Adams DD, Purves HD. Abnormal responses in the assay of thyrotropin. Proceedings of the University of Otago Medical School. 1956; 34: 11
   Google Scholar
• Adams DD, Fastier FN, Howie JB, et al. Stimulation of the human thyroid by infusions of plasma containing LATS protector. J Clin Endocrinol Metab 1974; 39: 826
   PubMedGoogle Scholar
• Fisher DA. Neonatal thyroid disease in the offspring of mothers with autoimmune thyroid disease. Thyroid Today 1986; 9: 1
   Google Scholar
• Morgenthaler NG. New assay systems for thyrotropin receptor antibodies. Curr Opin Endocrinol Diabetes 1998; 6: 251–260
   Google Scholar
• Kamijo K, Nagata A, Sato Y. Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves' disease using polyethylene glycol at high concentration and porcine thyroid cells. Endocrinol J 1999; 46: 397–403
   PubMed Web of Science ®Google Scholar
• Takasu N, Yamashiro K, Ochi Y, Sato Y, Nagata A, Komiya I, et al. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism. Horm Metab Res 2001; 33: 232–237
   PubMed Web of Science ®Google Scholar
• Akamizu T, Inoue D, Kosugi S, Kohn LD, Mori T. Further studies of amino acids (268–304) in thyrotropin (TSH)-lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: Cysteine-301 is important in TSH binding and receptor tertiary structure. Thyroid 1994; 4: 43–48
   PubMed Web of Science ®Google Scholar
• Grasso YZ, Kim MR, Faiman C, Kohn LD, Tahara K, Gupta MK. Epitope heterogeneity of thyrotropin-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors. Thyroid 1999; 9: 521–537
   PubMedGoogle Scholar
• Kim WB, Chung HK, Lee HK, Kohn LD, Tahara K, Cho BY. Changes in epitopes for thyroid stimulation antibodies in Graves' disease sera during treatment of hyperthyroidism: Therapeutic implications. J Clin Endocrinol Metab 1997; 82: 1953–1959
   PubMed Web of Science ®Google Scholar
• Shewring G, Smith BR. An improved radioreceptor assay for TSH receptor. Methods Enzymol 1982; 17: 409–417
   Google Scholar
• Costagliola S, Morganthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999; 84: 90–97
   PubMed Web of Science ®Google Scholar
• Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA, Seissler J. Detecting TSH-receptor antibodies with the recombinant TBII assay: Technical and clinical evaluation. Horm Metab Res 2000; 32: 429–435
   PubMedGoogle Scholar
• Giovanella L, Ceriani L, Garancini S. Clinical applications of the 2nd. generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st. generation test. Clin Chem Lab Med 2001; 39: 25–28
   PubMedGoogle Scholar